Insider Selling: Horizon Therapeutics Public Limited (NASDAQ:HZNP) EVP Sells 762 Shares of Stock

Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) EVP Andy Pasternak sold 762 shares of the company’s stock in a transaction dated Friday, June 10th. The stock was sold at an average price of $85.36, for a total transaction of $65,044.32. Following the completion of the sale, the executive vice president now directly owns 38,897 […]

Related Keywords

Andy Pasternak ,Morgan Stanley ,Horizon Therapeutics Public ,Hightower Advisors ,Nasdaq ,Capital Partners ,Guggenheim Capital ,Wells Fargo Company ,Horizon Therapeutics Public Limited ,Dynamic Technology Lab Private Ltd ,Horizon Therapeutics Public Limited Company ,Get Rating ,Therapeutics Public Limited ,Therapeutics Public ,Tower Advisors ,Technology Lab Private Ltd ,Therapeutics Public Limited Company ,Nasdaq Hznp ,Hznp ,Medical ,44047t10 ,Insider Trading ,Nsider Trades ,Stocks ,